CAR T-Cell Therapy in ALL: Formidible Challenges Remain
April 4, 2018
At the NCCN Annual Conference, Dr. Bijal Shah of Tampa’s Moffitt Cancer Center highlighted ongoing challenges in administration of CAR T-cell therapy.
Roxanne Nelson
New Oncology Care Model Unfolds From CMS
April 3, 2018
During the NCCN Annual Conference, Ron Kline, MD, FAAP, from CMS’s Innovation Center, discussed the Center’s pilot Oncology Care Model.
Treatment for Triple-Negative Breast Cancer Slowly Moving Forward
March 26, 2018
Triple-negative breast cancer treatments being investigated include checkpoint inhibitors, agents that target the androgen receptor pathways, and antibody-drug conjugates.
Evolving Treatment for Advanced Melanoma: More Questions Than Answers
March 26, 2018
At the NCCN Annual Conference in Orlando, Dr. April Salama discussed targeted treatment options in first- and second-line therapy for advanced melanoma.
Treatment Options Expanding in Renal Carcinoma
March 26, 2018
First- and second-line treatment of clear cell RCC has changed dramatically, Dr. Eric Jonasch said during the NCCN Annual Conference in Orlando.
‘Screening Smarter’ for Prostate Cancer
March 23, 2018
During the NCCN Annual Conference in Orlando, Dr. Peter Carroll from UCSF discussed the evolution of screening tests for prostate cancer.
Despite Evolving Treatment for Ovarian Cancer, Late Diagnosis Remains a Challenge
March 23, 2018
PARP inhibitors are offering new treatment options for ovarian cancer patients with known mutations, but early-stage diagnosis is still elusive.
